Glaxosmithkline | GSK - Equity Capital And Reserves

Stock Price
59.84
Daily Change
11.55 23.92%
Monthly
22.85%
Yearly
66.04%
Q1 Forecast
50.58

Glaxosmithkline reported GBP21.7B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -2.64B 2.46B Sep/2025
Amgen USD 9.62B 2.19B Sep/2025
AstraZeneca USD 45.89B 1.17B Sep/2025
Aurora Cannabis CAD 567.1M 21.58M Sep/2025
Bausch Health Companies USD 356M 209M Sep/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Canopy Growth CAD 736.01M 247.04M Sep/2025
Corcept Therapeutics USD 631.9M 3.89M Sep/2025
Drreddys Laboratories INR 4.14B 107.72M Dec/2025
Eli Lilly USD 23.79B 5.52B Sep/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
Glaxosmithkline GBP 21.7B 7.35B Sep/2025
J&J USD 78.47B 0 Sep/2025
Merck USD 51.85B 2.79B Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
Pacira USD 727.21M 30.55M Sep/2025
Perrigo USD 4.45B 25.8M Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Prestige Brands USD 1.83B 4.48M Dec/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 71.71B 1.55B Dec/2025
Supernus Pharmaceuticals USD 1.05B 14.23M Sep/2025
Takeda JPY 7.64T 513.39B Dec/2025
Teva Pharmaceutical Industries USD 7.91B 664M Dec/2025
Zoetis USD 5.4B 421M Sep/2025